• 1
    Adult Treatment Panel III. (2003) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA. 285: 24862497.
  • 2
    Alberti, K. G., Zimmet, PZ. (1998) Definition, diagnosis and classification of diabetes mellitus and its complications: I. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 15: 539553.
  • 3
    Reaven, GM. (1988) Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 37: 15951607.
  • 4
    Cnop, M., Landchild, M. J., Vidal, J., et al (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 51: 10051015.
  • 5
    Haffner, SM. (2003) Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract. 61(Suppl 1): S9S18.
  • 6
    Ronnemaa, T., Koskenvuo, M., Marniemi, J., et al (1997) Glucose metabolism in identical twins discordant for obesity: the critical role of visceral fat. J Clin Endocrinol Metab. 82: 383387.
  • 7
    Isomaa, B., Almgren, P., Tuomi, T., et al (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24: 683689.
  • 8
    Reaven, G., Abbasi, F., McLaughlin, T. (2004) Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 59: 207223.
  • 9
    Bergman, R. N., Ider, Y. Z., Bowden, C. R., Cobelli, C. (1979) Quantitative estimation of insulin sensitivity. Am J Physiol. 236: E667E677.
  • 10
    Kahn, S. E., Prigeon, R. L., McCulloch, D. K., et al (1993) Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function. Diabetes. 42: 16631672.
  • 11
    Polonsky, K. S., Given, B. D., Hirsch, L., et al (1988) Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 881: 435441.
  • 12
    Caro, J. F., Sinha, M. K., Raju, S. M., et al (1987) Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest. 79: 13301337.
  • 13
    Mostaza, J. M., Vega, G. L., Snell, P., Grundy, SM. (1998) Abnormal metabolism of free fatty acids in hypertriglyceridaemic men: apparent insulin resistance in adipose tissue. J Intern Med. 243: 265274.
  • 14
    Jensen, M. D., Haymond, M. W., Rizza, R. A., Cryer, P. E., Miles, JM. (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 83: 11681173.
  • 15
    DeFronzo, R. A., Bonadonna, R. C., Ferrannini, E. (1992) Pathogenesis of NIDDM: a balanced overview. Diabetes Care. 15: 318368.
  • 16
    Randle, P. J., Garland, P. B., Hales, C. N., Newsholme, EA. (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1: 785789.
  • 17
    Boden, G., Chen, X., Ruiz, J., White, J. V., Rossetti, L. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest. 93: 24382446.
  • 18
    Arner, P. (2002) Insulin resistance in type 2 diabetes: role of fatty acids. Diabetes Metab Res Rev. 18(Suppl 2): S5S9.
  • 19
    Santomauro, A. T., Boden, G., Silva, M. E., et al (1999) Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. 48: 18361841.
  • 20
    Bogardus, C., Lillioja, S., Stone, K., Mott, D. (1984) Correlation between muscle glycogen synthase activity and in vivo insulin action in man. J Clin Invest. 73: 11851190.
  • 21
    Dresner, A., Laurent, D., Marcucci, M., et al (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest. 103: 253259.
  • 22
    Shulman, GI. (2000) Cellular mechanisms of insulin resistance. J Clin Invest. 106: 171176.
  • 23
    Boden, G., Shulman, GI. (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest. 32(Suppl 3): 1423.
  • 24
    Boden, G., Chen, X., Capulong, E., Mozzoli, M. (2001) Effects of free fatty acids on gluconeogenesis and autoregulation of glucose production in type 2 diabetes. Diabetes. 50: 810816.
  • 25
    Williamson, J. R., Kreisberg, R. A., Felts, PW. (1966) Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci U S A. 56: 247254.
  • 26
    Weyer, C., Tataranni, P. A., Bogardus, C., Pratley, RE. (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care. 24: 8994.
  • 27
    Unger, R. H., Zhou, YT. (2001) Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes. 50(Suppl 1): S118S121.
  • 28
    Beltowski, J. (2003) Adiponectin and resistin: new hormones of white adipose tissue. Med Sci Monit. 9: RA55RA61.
  • 29
    Weyer, C., Funahashi, T., Tanaka, S., et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86: 19301935.
  • 30
    Berg, A. H., Combs, T. P., Scherer, PE. (2002) ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 13: 8489.
  • 31
    Yamauchi, T., Kamon, J., Minokoshi, Y., et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 8: 12881295.
  • 32
    Steppan, C. M., Bailey, S. T., Bhat, S., et al (2001) The hormone resistin links obesity to diabetes. Nature. 409: 307312.
  • 33
    Rajala, M. W., Obici, S., Scherer, P. E., Rossetti, L. (2003) Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 111: 225230.
  • 34
    Krentz, AJ. (2003) Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab. 5(Suppl 1): S19S27.
  • 35
    Ferrannini, E., Natali, A., Capaldo, B., Lehtovirta, M., Jacob, S., Yki-Jarvinen, H. (1997) Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension. 30: 11441149.
  • 36
    Blake, G. J., Ridker, PM. (2001) Novel clinical markers of vascular wall inflammation. Circ Res. 89: 763771.
  • 37
    Das, UN. (2002) Obesity, metabolic syndrome X, and inflammation. Nutrition. 18: 430432.
  • 38
    Yudkin, JS. (2003) Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 27(Suppl 3): S25S28.
  • 39
    Collins, R., Peto, R., MacMahon, S., et al (1990) Blood pressure, stroke, and coronary heart disease: II. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 335: 827838.
  • 40
    Kohler, H. P., Grant, PJ. (2000) Plasminogen-activator inhibitor type I and coronary artery disease. N Engl J Med. 342: 17921801.
  • 41
    Seppala-Lindroos, A., Vehkavaara, S., Hakkinen, A. M., et al (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 87: 30233028.
  • 42
    Clark, J. M., Diehl, AM. (2002) Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep. 2: 210215.
  • 43
    Kelley, D. E., McKolanis, T. M., Hegazi, R. A., Kuller, L. H., Kalhan, SC. (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 285: E906E916.
  • 44
    Chitturi, S., Farrell, GC. (2001) Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis. 21: 2741.
  • 45
    Sanyal, A. J., Campbell-Sargent, C., Mirshahi, F., et al (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 20: 11831192.
  • 46
    Pi-Sunyer, FX. (1996) A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity. Clin Ther. 18: 10061035.
  • 47
    Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al (2002) Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346: 393403.
  • 48
    Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344: 13431350.
  • 49
    Heart Protection Study Collaborative Group. (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360: 722.
  • 50
    Adler, AI. (2001) Cardiovascular risk reduction in diabetes: underemphasized and overdue: messages from major trials. Clin Med. 1: 472477.
  • 51
    Grundy, SM. (1999) The optimal ratio of fat-to-carbohydrate in the diet. Annu Rev Nutr. 19: 325341.
  • 52
    Assmann, G., Schulte, H. (1988) The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J. 116: 17131724.
  • 53
    Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D. (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 16: 434444.
  • 54
    Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K., Laakso, M. (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339: 229234.
  • 55
    Miettinen, H., Lehto, S., Salomaa, V., et al (1998) Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care. 21: 6975.
  • 56
    Pyorala, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G. (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care. 20: 614620.
  • 57
    UK Prospective Diabetes Study Group. (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J. 317: 703713.
  • 58
    Gaede, P., Vedel, P., Larsen, N., Jensen, G. V., Parving, H. H., Pedersen, O. (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 348: 383393.
  • 59
    Appel, L. J., Moore, T. J., Obarzanek, E., et al (1997) A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 336: 11171124.
  • 60
    Svetkey, L. P., Harsha, D. W., Vollmer, W. M., et al (2003) Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics. Ann Epidemiol. 13: 462471.
  • 61
    Haffner, SM. (1997) Epidemiology of hypertension and insulin resistance syndrome. J Hypertens. 5: S25S30.
  • 62
    Hsueh, W. A., Law, RE. (1999) Insulin signaling in the arterial wall. Am J Cardiol. 84: 2124J.
  • 63
    Koshiyama, H., Shimono, D., Kuwamura, N., Minamikawa, J., Nakamura, Y. (2001) Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 86: 34523456.
  • 64
    Buchanan, T. A., Xiang, A. H., Peters, R. K., et al (2002) Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes. 51: 27962803.
  • 65
    Maki, KC. (2004) Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am J Cardiol. 93: 1217C.